Rakar S - Search Results

1

Human papillomavirus infection in relation to mild dyskaryosis in conventional cervical cytology.

Vrtacnik Bokal E, Rakar S, Mozina A, Poljak M. Vrtacnik Bokal E, et al. Among authors: rakar s. Eur J Gynaecol Oncol. 2005;26(1):39-42. Eur J Gynaecol Oncol. 2005. PMID: 15754998

2

Role of human papillomavirus testing in reducing the number of surgical treatments for precancerous cervical lesions.

Vrtacnik-Bokal E, Rakar S, Jancar N, Mozina A, Poljak M. Vrtacnik-Bokal E, et al. Among authors: rakar s. Eur J Gynaecol Oncol. 2005;26(4):427-30. Eur J Gynaecol Oncol. 2005. PMID: 16122194

3

Clinical audit of patients with cervical cancer in Slovenia--data analysis for the year 2003.

Ursic-Vrscaj M, Rakar S, Mozina A, Takac I, Gubic Z, Kodric T, Smrkolj S. Ursic-Vrscaj M, et al. Among authors: rakar s. Eur J Gynaecol Oncol. 2005;26(5):537-42. Eur J Gynaecol Oncol. 2005. PMID: 16285574

4

Efficiency of three surgical procedures in eliminating high-risk human papillomavirus infection in women with precancerous cervical lesions.

Jancar N, Rakar S, Poljak M, Fujs K, Kocjan BJ, Vrtacnik-Bokal E. Jancar N, et al. Among authors: rakar s. Eur J Gynaecol Oncol. 2006;27(3):239-42. Eur J Gynaecol Oncol. 2006. PMID: 16800249

5

Clinical audit of patients with cervical cancer in Slovenia. Data analysis from 2003-2006.

Ursic-Vrscaj M, Rakar S, Mozina A, Takac I, Bebar S, Subic Z, Kodric T, Smrkolj S. Ursic-Vrscaj M, et al. Among authors: rakar s. Eur J Gynaecol Oncol. 2008;29(6):628-32. Eur J Gynaecol Oncol. 2008. PMID: 19115692

6

Evaluation of causes of increased incidence of cervical cancer in Slovenia.

Smrkolj S, Rakar S, Mozina A, Erzen M. Smrkolj S, et al. Among authors: rakar s. Eur J Obstet Gynecol Reprod Biol. 2004 Dec 1;117(2):213-21. doi: 10.1016/j.ejogrb.2004.06.002. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15541860

7

Prognostic factors in ovarian cancer.

Rakar S, Kovacic J, Cavic M, Lukanovic A, Mozina A. Rakar S, et al. Eur J Gynaecol Oncol. 1990;11(3):171-3. Eur J Gynaecol Oncol. 1990. PMID: 2170137

8

Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia.

Takac I, Ursic-Vrscaj M, Repse-Fokter A, Kodric T, Rakar S, Mozina A, Smrkolj S, Primic-Zakelj M, Strzinar V, Vakselj A, Arko D. Takac I, et al. Among authors: rakar s. Eur J Obstet Gynecol Reprod Biol. 2008 Sep;140(1):82-9. doi: 10.1016/j.ejogrb.2008.02.019. Epub 2008 Apr 8. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 18400358

9

Prognostic significance of topoisomerase II alpha and collagen IV immunoexpression in cervical cancer.

Smrkolj S, Erzen M, Rakar S. Smrkolj S, et al. Among authors: rakar s. Eur J Gynaecol Oncol. 2010;31(4):380-5. Eur J Gynaecol Oncol. 2010. PMID: 20882877

10

Risk factors and prognostic factors in patients with double primary cancer: epithelial ovarian cancer and breast cancer.

Cvelbar M, Ursic-Vrscaj M, Rakar S. Cvelbar M, et al. Among authors: rakar s. Eur J Gynaecol Oncol. 2005;26(1):59-63. Eur J Gynaecol Oncol. 2005. PMID: 15755003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters